Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, Dusek L, Fadda P, Micale V, Sulcova A, Fratta W, Fattore L.

Front Pharmacol. 2014 Mar 20;5:44. doi: 10.3389/fphar.2014.00044. eCollection 2014.

2.

Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats.

Babinska Z, Ruda-Kucerova J, Amchova P, Merhautova J, Dusek L, Sulcova A.

Behav Brain Res. 2016 Jan 15;297:20-7. doi: 10.1016/j.bbr.2015.09.035. Epub 2015 Oct 22.

PMID:
26431766
3.

The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression.

Kucerova J, Pistovcakova J, Vrskova D, Dusek L, Sulcova A.

Int J Neuropsychopharmacol. 2012 Nov;15(10):1503-11. doi: 10.1017/S1461145711001684. Epub 2011 Nov 25.

PMID:
22114789
4.

Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.

Nguyen KQ, Tohyama Y, Watanabe A, Hasegawa S, Skelin I, Diksic M.

Neurochem Int. 2009 Mar-Apr;54(3-4):161-71. doi: 10.1016/j.neuint.2008.08.012. Epub 2008 Nov 27.

5.

Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.

Watanabe A, Hasegawa S, Nishi K, Nguyen KQ, Diksic M.

Brain Res Bull. 2006 Mar 31;69(2):101-8. Epub 2005 Dec 9.

PMID:
16533657
6.

Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats.

Kalshetti PB, Alluri R, Mohan V, Thakurdesai PA.

Pharmacogn Mag. 2015 Oct;11(Suppl 3):S388-96. doi: 10.4103/0973-1296.168980.

7.

Intravenous self-administration of amphetamine is increased in a rat model of depression.

Holmes PV, Masini CV, Primeaux SD, Garrett JL, Zellner A, Stogner KS, Duncan AA, Crystal JD.

Synapse. 2002 Oct;46(1):4-10.

PMID:
12211093
8.

Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration.

Lecca D, Cacciapaglia F, Valentini V, Di Chiara G.

Psychopharmacology (Berl). 2006 Sep;188(1):63-74. Epub 2006 Jul 19.

PMID:
16850116
9.

Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A.

J Neurochem. 2009 Mar;108(6):1423-33. doi: 10.1111/j.1471-4159.2009.05898.x. Epub 2009 Jan 22.

10.

Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.

Eisenstein SA, Holmes PV, Hohmann AG.

Synapse. 2009 Nov;63(11):941-50. doi: 10.1002/syn.20679.

11.

Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study.

Hasegawa S, Watanabe A, Nguyen KQ, Debonnel G, Diksic M.

Psychopharmacology (Berl). 2005 Jun;179(4):781-90. Epub 2004 Dec 24.

PMID:
15619103
12.

Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.

Fattore L, Spano MS, Altea S, Angius F, Fadda P, Fratta W.

Br J Pharmacol. 2007 Nov;152(5):795-804. Epub 2007 Sep 24.

13.

Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.

Sato H, Skelin I, Debonnel G, Diksic M.

Brain Res Bull. 2008 Mar 28;75(5):545-55. doi: 10.1016/j.brainresbull.2007.09.005. Epub 2007 Oct 11.

PMID:
18355630
14.

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.

Fattore L, Cossu G, Martellotta CM, Fratta W.

Psychopharmacology (Berl). 2001 Aug;156(4):410-6.

PMID:
11498718
15.

The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression.

Frankowska M, Jastrzębska J, Nowak E, Białko M, Przegaliński E, Filip M.

Behav Brain Res. 2014 Jun 1;266:108-18. doi: 10.1016/j.bbr.2014.02.044. Epub 2014 Mar 5.

PMID:
24613240
16.

Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study.

van der Stelt HM, Breuer ME, Olivier B, Westenberg HG.

Biol Psychiatry. 2005 May 1;57(9):1061-7.

PMID:
15860347
17.

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

Breuer ME, van Gaalen MM, Wernet W, Claessens SE, Oosting RS, Behl B, Korte SM, Schoemaker H, Gross G, Olivier B, Groenink L.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):101-6. doi: 10.1007/s00210-008-0336-1. Epub 2008 Jul 31.

PMID:
18668225
18.

Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B.

Biol Psychiatry. 2007 Apr 15;61(8):990-5. Epub 2006 Dec 4.

PMID:
17141743
19.

Influence of olfactory bulbectomy on maternal behavior and dopaminergic function in nucleus accumbens in mice.

Sato A, Nakagawasai O, Tan-No K, Onogi H, Niijima F, Tadano T.

Behav Brain Res. 2010 Dec 20;215(1):141-5. doi: 10.1016/j.bbr.2010.07.012. Epub 2010 Jul 16.

PMID:
20638419
20.

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.

Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B.

Eur J Pharmacol. 2009 Aug 15;616(1-3):134-40. doi: 10.1016/j.ejphar.2009.06.029. Epub 2009 Jun 21.

PMID:
19549514
Items per page

Supplemental Content

Write to the Help Desk